Leaving some breathing room in between the 3 Qs might be best. Also — for Henry to promise & follow through on *another* 3 CCs (vs 1) would only add to his credibility & the credibility of PHIL & future projects.
Having more 2021 CCs (and filings) than you can count on one hand is probably way more than any other OTC company can boast.